(PRNewsfoto/AACC)

Artificial intelligence in personalized medicine, advances in genomic sequencing, human brain organogenesis, building trust with patients, guiding patient decisions using mass spectrometry, and much more to be explored at the 2022 AACC Annual Scientific Meeting and Clinical Laboratory Exposition

ChicagoAnd the 24 July 2022 /PRNewswire/ — At the 2022 AACC Annual Scientific Meeting and Clinical Laboratory Expo, laboratory medicine experts will present the latest research and technology that is revolutionizing clinical testing and patient care. From July 24-28 in ChicagoOver 250 meeting sessions will provide insights on a wide range of healthcare topics in a timely manner. Highlights include discussions that explore the use of artificial intelligence (AI) in personalized medicine, advances in genetic sequencing and multiplex imaging, real-life applications to human brain organogenesis, how to build trust with patients, and guide clinical decisions using mass spectrometry.

(PRNewsfoto/AACC)

Artificial intelligence in personalized medicine. Precision medicine involves designing treatments for individual patients, and increasingly, clinicians are using artificial intelligence in their clinical prediction models to do so. In the opening speech of the meeting, Dr. Lucilla Ono MachadoAssociate Dean of Health Informatics and Technology at University of California San Diegohow AI models are developed, tested, and validated as well as performance measures that may help clinicians select these models for routine use.

Multiplex gene sequencing and imaging. Thanks to advances in multiplex genetic sequencing and imaging, we are able to identify small but crucial differences in DNA, RNA, proteins, and more. These technologies have also seen a 50 million-fold cost reduction and similar quality improvements since their debut. Despite this, healthcare is only just beginning to catch up on the effects of these technologies. Dr. George Churchthe recipient of the 2022 AACC Wallace H. Coulter Lectures Award and the founding core faculty and leadership of the Wyss Institute for Synthetic Biology at Harvard universityIn this plenary session, developments and implications for multiplexing technologies will be discussed.

Human brain organoid technology applications. The human brain is a highly complex biological system that is susceptible to many neurological and neurodegenerative disorders that affect millions of people worldwide. In this plenary session, Dr. Alison R. Mootri, professor of cellular and molecular medicine at University of California San Diego Medical School, you will explore the concept of organogenesis of the human brain, or how to recreate the human brain in a dish. The many applications of this technique in neurological care will be discussed.

Building trust in health care. The world is experiencing a crisis of confidence that is affecting the delivery of health care around the world. Dr. Thomas LeeThe Chief Medical Officer of Press Ganey Associates and Professor of Health Policy and Management at Harvard TH Chan School of Public Health, will describe the importance of building trust between patients and health care professionals in this plenary session. It will explore a three-component model for building trust, and the types of interventions most likely to be effective.

Guide clinical decisions using mass spectrometry. In this closing keynote of the meeting d. Livia Schiavenato BerlinAssociate Professor of Surgery and Director of Translation Research and Innovations at Baylor College of Medicine, will discuss the development and application of direct mass spectrometry techniques used in clinical microbiology laboratories, clinical pathology laboratories, and the operating room. The presentation will focus on results obtained in ongoing clinical studies using two direct mass spectrometry techniques, namely, absorption electrostatic spray ionization mass spectrometry and the MasSpec Pen technology.

In addition, at the Clinical Lab Expo, more than 750 exhibitors will showcase innovative technologies that are just coming to market in every clinical laboratory specialty.

“The ability of laboratory medicine to adapt to changing healthcare conditions and use the scientific insights of the field to improve quality of life is unparalleled. This ability is constantly increasing, with advanced diagnostic technologies emerging every day in fields as diverse as mass spectrometry and artificial intelligence,” said the AACC CEO: “Genetic sequencing, and neuroscience” Mark J Golden. “The 2022 AACC Annual Scientific Meeting will highlight the pioneers of laboratory medicine who are mobilizing these new developments to advance patient care.”

Session information

Registration for the AACC Annual Scientific Meeting is free for members of the media. Journalists can register online here: https://www.xpressreg.net/register/aacc0722/media/landing.asp

Artificial intelligence in personalized medicine

Session 11001 Biomedical Informatics Strategies to Enhance Individual Predictive Models
Sunday 24 July
5-6:30 p.m. CST

Multiplex gene sequencing and imaging

Session 12001 Multiplier and Incremental Improvement of Technologies
Monday 25 July
8:45 – 10:15 AM CST

Human brain organoid technology applications

Session 13001: Applications of Organoid Technology to the Human Brain
Tuesday 26 July
8:45 – 10:15 AM CST

Building trust in healthcare

Session 14001 Building Confidence in a Time of Troubles
Wednesday 27 July
8:45 – 10:15 AM CST

Guide clinical decisions using mass spectrometry

Session 15001 Guiding clinical decisions with molecular information provided by direct mass spectrometry techniques
Thursday 28 July
8:45 – 10:15 AM CST

All sessions will be held in Room S100 of the McCormick Place Convention Center in Chicago.

About the 2022 AACC Annual Scientific Meeting and Clinical Laboratory Exhibition
The AACC Annual Scientific Meeting offers 5 days full of opportunities to learn about exciting science from July 24-28. Plenary sessions will explore AI-based clinical prediction models, advances in multiplex techniques, human brain organogenesis, building trust between the public and healthcare experts, and direct mass spectrometry techniques.

At the AACC Clinical Lab Expo, more than 750 exhibitors will fill the show floor at McCormick Place Convention Center in Chicago With offerings of the latest diagnostic technologies, including but not limited to COVID-19 testing, artificial intelligence, mobile health, molecular diagnostics, mass spectrometry, point of care, and automation.

About AACC
Dedicated to achieving better health through laboratory medicine, the AACC brings together more than 70,000 clinical laboratory professionals, clinicians, research scientists, and business leaders from around the world who focus on clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, laboratory management, and more. Areas of advancement of laboratory sciences. Since 1948, the AACC has worked to advance the common interests of the field, by providing programs that promote scientific collaboration, knowledge, expertise, and innovation. For more information visit www.aacc.org.

Kristen DeLong
AACC
Senior Manager, Communications and Public Relations
(P) 202.835.8722
cdelong@aacc.org

molly poland
AACC
Senior Manager, Communications and Public Relations
(P) 202.420.7612
(C) 703.598.0472
mpolen@aacc.org

Cision

Cision

View original content for multimedia download:https://www.prnewswire.com/news-releases/artuate-intelligence-in-personalized-medicine-genomic-sequencing-advances-human-brain-organogenesis-building-trust-with-patients-guiding-patient-decisions- Using mass spectrometry and much more to explore in 2022-aac-301592069.html

Source AACC

#Artificial #intelligence #personalized #medicine #advances #genomic #sequencing #human #brain #organogenesis #building #trust #patients #guiding #patient #decisions #mass #spectrometry #explored #AACC #Annual #Scientific #Meeting #Clinical #Laboratory #Exposition

Leave a Comment

Your email address will not be published.